✈ CPHI, here we come!
We are very close to the new edition of CPHI, the heart of Pharma for 30 years. This year our Business Director Sergio Fasan in his speech entitled "𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗻𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲𝘀 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀: 𝗮 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗰𝗼𝗺𝗽𝗹𝗲𝘅 𝗻𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲𝘀 (𝗡𝗗𝗦𝗥𝗜𝘀)" will address four specific focuses:
. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗼𝗻 𝗻𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲𝘀 in major industries and regulatory updates
. 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗮𝗻𝗱 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗶𝘀𝘀𝘂𝗲𝘀 in the development of highly sensitive analytical methods
. Analytical issues in the determination of specific 𝗡𝗗𝗦𝗥𝗜s
. Case studies
💡 You can listen to Sergio Fasan's speech on 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟰 (𝗖𝗘𝗧), 𝗳𝗿𝗼𝗺 𝟯:𝟬𝟬 𝘁𝗼 𝟯:𝟮𝟱 𝗽𝗺, 𝗮𝘁 𝗥𝗼𝗼𝗺 𝟰.𝟮, 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗖𝗲𝗻𝘁𝗲𝗿 𝟰. So don't miss the appointment! And don't forget to visit us also at our booth, 3Q29, where you will find all our experts.
#Mxns#MxnsEvent#Pharma
At Sannova, we care about your goals. Our dedicated team stands by your side, unwavering in our commitment to providing the highest quality of scientific support.
Aligned with your mission, we champion the delivery of top-tier analytical and bioanalytical solutions, supporting the advancement of drug development.
Our #digitaltransformation is enabling us to be more agile and manage risk in our supply chains, setting you up for best results.
Meet us at #AAPS2023, booth 2450 (#pharmsci360) to learn more.
What does it take to create a more patient-friendly trial? We're exploring that and more at BioPharma Nexus. Thanks to everyone who has talked with us about how HeartcoR can improve compliance and give your next trial a competitive edge. #BioPharmaNexus#CoreLab#ClinicalTrialshttps://loom.ly/itbcW-Y
We are less than 1 week away to the start of VAM Week 2023! This event is virtual and is FREE but registration is required - spaces are quickly filling up, reserve your spot today!
Featured Speaker of the Week:
William Salminen, PhD, DABT, PMP (Premier Consulting) will be presenting during the Development Track: "Combination Products and Digital Health – Technical Challenges and Opportunities" Session.
This session will cover the nuances of the regulatory and commercial aspects of combination product development, including the 505(b)(2) NDA pathway, and how to leverage existing information for the drug and/or device constituent components to streamline overall combination product development, including combination products that incorporate a digital device component. A case study of the development, regulatory approval, and commercialization of the Digihaler device will be presented.
Register Today! https://lnkd.in/edw6D6hk#VAMWeek#SAAMnow#pharma#pharmaevents#drugdevelopment#genericdrugs#FDA#505b2#virtualevents
"Unleash the Power of Innovation! Join us at 19th BioPharma Clinical Trials Nexus Conference where ideas transform into action, and connections pave the way for a future of possibilities. Secure your spot now!
#19th BioPharma Clinical Trials Nexus Conference"
Elligo Health Research is patient-first and incorporates AI technology to empower patients, sites, and sponsors that we serve.
Exciting news!
Elligo Health Research®, the largest healthcare-enabling research organization, announced a partnership with Avallano, a data privacy and healthcare technology company, to launch myTrialsConnectSM, a scalable research community powered by artificial intelligence (AI), that was built to serve patients, providers, sites, and the biopharma industry.
Feel free to PM if you'd like to learn more. We are happy to assist with your clinical trial needs.
#clinicalresearch#sites#technology#psychedelicresearch#AI
Today we announced a new partnership with Avallano to build myTrialsConnectSM, a patient-first, AI-powered research community. Here’s how it will serve patients, providers, sites, and the biopharma industry: https://lnkd.in/gkaT-zci
✈ Let´s meet in San Francisco! 🌉
CSO Andreas Pahl and CBO George Octavian Badescu start Heidelberg Pharma´s business year with a trip to the #jpm2024 week.
Learn more about Heidelberg Pharma´s unique ADC-technology based on the toxin Amanitin and find a strategic partner to advance your company! Please reach out to use directly or email bd@hdpharma.com to make an appointment to discuss potential collaborations in #ATAC#ADCtechnology#cancerresearch